• Next generation adenovirus vector

    Next generation adenovirus vector

    Empowering Immune Boosting, Oncolytic Cancer
    Treatments, Gene Delivery and CRISPR/Cas9 Treatments

    Learn more
  • bildspel-cd70-1

    The cd70 platform

    Enabling Superior Expansion and Longevity of Tumor Specific CAR T-Cells for adoptive immunotherapy

    Learn more
  • The combig platform

    Meet our COMBIG-platform

    Enabling off-the-shelf, cell-based cancer
    immune primers for personalized treatment

    Learn more

Immunicum is listed on NASDAQ OMX First North under the ticker IMMU.

About us

Developing innovative cancer immunotherapies

We are on a journey towards the world’s first patient unique, off-the-shelf cancer treatment. Get to know the technology that will take us there.

Learn more
About